GLOBUS MEDICAL, INC. Business Acquisition, Pro Forma Revenue
GLOBUS MEDICAL, INC. (GMED) reported Business Acquisition, Pro Forma Revenue of $585.48 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2023-11-07
- GLOBUS MEDICAL, INC. business acquisition, pro forma revenue for the quarter ending 2023-09-30 was $585.48M, a 6.56% increase year-over-year.
- GLOBUS MEDICAL, INC. business acquisition, pro forma revenue for the quarter ending 2022-09-30 was $549.43M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 9 month |
|---|---|---|
| 2023-09-30 | $585.48M 10-Q · filed 2023-11-07 | $1.78B 10-Q · filed 2023-11-07 |
| 2022-09-30 | $549.43M 10-Q · filed 2023-11-07 | $1.64B 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |